BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24006461)

  • 1. Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells.
    Kawashima H; Takatori H; Suzuki K; Iwata A; Yokota M; Suto A; Minamino T; Hirose K; Nakajima H
    J Immunol; 2013 Oct; 191(7):3614-23. PubMed ID: 24006461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
    Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
    J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity.
    Gokhale AS; Gangaplara A; Lopez-Occasio M; Thornton AM; Shevach EM
    J Autoimmun; 2019 Dec; 105():102300. PubMed ID: 31296356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p27(Kip1) inhibits systemic autoimmunity through the control of Treg cell activity and differentiation.
    Iglesias M; Postigo J; Santiuste I; González J; Buelta L; Tamayo E; Merino J; Merino R
    Arthritis Rheum; 2013 Feb; 65(2):343-54. PubMed ID: 23124840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation controls Foxp3 gene expression.
    Polansky JK; Kretschmer K; Freyer J; Floess S; Garbe A; Baron U; Olek S; Hamann A; von Boehmer H; Huehn J
    Eur J Immunol; 2008 Jun; 38(6):1654-63. PubMed ID: 18493985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Default" generation of neonatal regulatory T cells.
    Wang G; Miyahara Y; Guo Z; Khattar M; Stepkowski SM; Chen W
    J Immunol; 2010 Jul; 185(1):71-8. PubMed ID: 20498359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Foxp3 function and expression in the thymic epithelium.
    Liston A; Farr AG; Chen Z; Benoist C; Mathis D; Manley NR; Rudensky AY
    J Exp Med; 2007 Mar; 204(3):475-80. PubMed ID: 17353370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.
    Rubtsov YP; Rasmussen JP; Chi EY; Fontenot J; Castelli L; Ye X; Treuting P; Siewe L; Roers A; Henderson WR; Muller W; Rudensky AY
    Immunity; 2008 Apr; 28(4):546-58. PubMed ID: 18387831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
    Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
    J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
    Wan YY; Flavell RA
    Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.
    Mayer CT; Floess S; Baru AM; Lahl K; Huehn J; Sparwasser T
    Eur J Immunol; 2011 Mar; 41(3):716-25. PubMed ID: 21312192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IκB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor.
    Schuster M; Glauben R; Plaza-Sirvent C; Schreiber L; Annemann M; Floess S; Kühl AA; Clayton LK; Sparwasser T; Schulze-Osthoff K; Pfeffer K; Huehn J; Siegmund B; Schmitz I
    Immunity; 2012 Dec; 37(6):998-1008. PubMed ID: 23200824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-bound Dickkopf-1 in Foxp3
    Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
    Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells.
    Jang E; Cho WS; Cho ML; Park HJ; Oh HJ; Kang SM; Paik DJ; Youn J
    J Immunol; 2011 Feb; 186(3):1546-53. PubMed ID: 21209284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
    Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
    Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
    Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
    Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
    Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
    J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.